ACTIV-3: Therapeutics for Inpatients With COVID-19
Clinical trial NCT04501978 · COMPLETED
Trial details
- NCT number
- NCT04501978
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2022-04-06
- Enrollment
- 2753
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.